SAFIR02_Lung - Efficacy of Targeted Drugs Guided by Genomic Profils in Metastatic NSCLC PatientsSAFIR02_Breast - Efficacy of Genome Analysis as a Therapeutic Decision Tool for Patients With Metastatic Breast CancerImmunization Strategy With Intra-tumoral Injections of Pexa-Vec With Ipilimumab in Metastatic / Advanced Solid Tumors.Immunotherapy With TG4010 in Patients With Advanced Non-Small Cell Lung CancerImmunotherapy With Neo-adjuvant Chemotherapy for OVarian CancerEvaluation of BD Glucan in Peritoneal Fluid for the Diagnosis of Fungal PeritonitisAn Efficacy and Safety Study of Azacitidine Subcutaneous in Combination With Durvalumab (MEDI4736) in Previously Untreated Subjects With Higher-Risk Myelodysplastic Syndromes (MDS) or in Elderly Subjects With Acute Myeloid Leukemia (AML)A Safety and Efficacy Study of Oral AG-120 Plus Subcutaneous Azacitidine and Oral AG-221 Plus Subcutaneous Azacitidine in Subjects With Newly Diagnosed Acute Myeloid Leukemia (AML)An Efficacy and Safety Study of AG-221 (CC-90007) Versus Conventional Care Regimens in Older Subjects With Late Stage Acute Myeloid Leukemia Harboring an Isocitrate Dehydrogenase 2 MutationProspective Study of the Prognostic Value of New Markers in Adults With ALK-positive Large Anaplastic LymphomaStudy to Assess Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of RO7112689 in Healthy Volunteers and Participants With Paroxysmal Nocturnal HemoglobinuriaAxillary Sentinel Lymph Node Detection in Breast Cancers > 2 cmGemcitabine With or Without Capecitabine and/or Radiation Therapy or Gemcitabine With or Without Erlotinib in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed by SurgeryA Trial of Romidepsin for Progressive or Relapsed Peripheral T-cell LymphomaA Study of CC-5013 Plus Dexamethasone Versus Dexamethasone Alone in Previously Treated Subjects With Multiple MyelomaRadiation Therapy With or Without Goserelin in Treating Patients Who Have Undergone Surgery for Recurrent or Refractory Prostate CancerSecond-line Treatment in Patients With Small Cell Lung Cancer (SCLC)Study of Pralatrexate With Vitamin B12 and Folic Acid in Patients With Relapsed or Refractory Peripheral T-cell LymphomaA Phase 3 Study of Brentuximab Vedotin (SGN-35) in Patients at High Risk of Residual Hodgkin Lymphoma Following Stem Cell Transplant (The AETHERA Trial)DNA Repair Inhibitor & Irradiation on MelanomaStudy of MK 2206 in Patients With Relapsed or Refractory Diffuse Large B Cell LymphomaValidation of a New TSH TestComparison of HT Concomitant With RT vs RT Alone in Patients With a Detectable PSA After ProstatectomyEfficacy Study Comparing Velcade Dexamethasone Thalidomide Versus Velcade Cyclophosphamide Dexamethasone as Induction Treatment in the Initial Management of Multiple Myeloma (IFM2013-04)A Study of Rucaparib as Switch Maintenance Following Platinum-Based Chemotherapy in Patients With Platinum-Sensitive, High-Grade Serous or Endometrioid Epithelial Ovarian, Primary Peritoneal or Fallopian Tube CancerPreemptive Therapy for High Risk Chronic Lymphoid Leukemia Stage AUTOLA: UTerin OLAparibTRuE AD1 - An Efficacy and Safety Study of Ruxolitinib Cream in Adolescents and Adults With Atopic DermatitisIdentification by Cytometry by Mass of Predictive Immunological Profiles of Answer to Treatmentby Biotherapics for Patients With Crohn's DiseaseEfficacy & Safety of rAd-IFN Administered With Celecoxib & Gemcitabine in Patients With Malignant Pleural MesotheliomaWomen's Evaluation of the Childbirth Experience: From Pregnancy to PostpartumRefractory Diffuse Large B-cell LymphomaAnti-PD-1 and Chemotherapy for R/R Hodgkin LymphomaMedico-economic Evaluation of the ONCORAL Program for Ambulatory Patients Under Oral Anticancer Drugs Versus Usual CareImmune Response to Vaccinations in Hematopoietic Stem Cell Transplant RecipientsStudy of the Outcome of Patients With Acute Myeloblastic Leukemia and Myelodysplastic Syndrome Receiving Iron Chelation Therapy After Allogeneic Hematopoietic Stem Cell TransplantationRadiation Therapy and Docetaxel With Either Fluorouracil or Cisplatin as First-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer That Cannot Be Removed By SurgeryCombination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Pancreatic CancerTriptorelin, Flutamide, and External-Beam Radiation Therapy or External-Beam Radiation Therapy Alone in Treating Patients With Stage II or Stage III Prostate CancerRadiation Therapy in Treating Older Women Who Are Undergoing Surgery for Stage I or Stage II Breast Cancer
P6153
Q58407795-EE400949-BFD7-4344-8F83-13E959FDF086Q58407870-F6D78C48-293E-48D9-92EE-729E30A37BB4Q58845956-8E4175E9-32BD-4FE1-8964-43545B533DE9Q58849116-92739368-1D03-4781-97B1-9AC3010F03DCQ58850054-90BCB1FB-B573-4740-A480-4C7D670B626BQ61729670-AF9D3ACE-36CA-4D7C-8E54-3F206A1A5623Q61862174-5AE334FA-AE87-4E20-9203-8E2913A4CC9CQ61862214-E5E7A0DD-3667-46B0-90B6-868E8DEBC5E3Q61862232-DE826C11-7936-4F2B-B770-0DF0F6A73C9CQ61907453-29D7AAAB-C236-4A5F-977B-568796819B75Q61909489-4DA7D8F9-461B-4895-95B3-8BFC00888826Q61915324-52231327-2E79-4097-80A2-5EF6BA5391DEQ61915483-37089531-2C63-4B33-B073-008998CAA858Q61921409-4A75B0B5-0E8A-4A17-8019-630CF26BCDD7Q61921635-2105E6CD-4BBA-491D-AF5C-4453F5C98B8AQ61921688-F7CD93E1-853F-47EF-BB90-47F23A6994D0Q61922160-8A18D6F5-7F2E-4659-87D1-C5473B3DF09AQ61934419-F1C1AAF2-F4AD-4B4D-9303-2E1747014707Q61936104-FE01351F-0AC7-4C28-98E7-D7CF81AC4975Q61955790-C36A6D36-56CE-48EA-B0D3-4634D9420E60Q61956261-1F43C662-F7EF-4FDC-940C-490185AA6B0CQ61969516-D18AC04D-BE4A-4347-B6E0-8737A0CEE24CQ61969792-9D80078D-12D1-45DF-8ED2-CCCC5B67CCB8Q61975265-8762D708-01B0-43C3-B9B7-AAB7B78B5606Q61975530-E303393C-D95B-40FF-9F81-2B35D5807A41Q62031687-C93BE67E-0758-4A1B-93EB-694F45D86C6DQ62034461-F4F17B7E-331F-42BD-9701-208F9DD85E85Q62034485-C443CF87-2F3F-4F84-B1A0-B9A356E1FCBEQ62041580-E449CEE2-97A1-4CD8-B866-0FBFEF1C75A0Q62042002-D9D2C9C2-D747-4014-BB18-9A6567FAE13CQ62054372-E55CB734-88B8-4857-A460-94E43A424870Q62062078-C5BF84E1-C68B-463A-89D9-D81BFFB62B01Q62062079-4A2566D8-7309-4A16-8E94-E16367C796D1Q62062363-72289D5D-77C8-4AF4-BF54-317C833D35EAQ62062433-F5CD2D24-351B-4CDB-B6A0-11A9ACBB431CQ62062488-75210C44-FE40-447A-BDF9-64B1952E0477Q62105028-D6DE40FD-D306-4DEB-8249-4B7A4CCB2A6FQ62105033-CE11ADCC-A553-4FEE-A7B2-3726D71D1C26Q62105842-80647358-4A24-4849-AC10-9B11CC3E93D4Q62105846-6A1110A4-AD69-4F72-A857-603A93FBB6A2
P6153
description
centre hospitalier français
@fr
name
centre hospitalier Lyon Sud
@fr
type
label
centre hospitalier Lyon Sud
@fr
altLabel
CHLS
@fr
Centre Hospitalier Lyon Sud
@fr
Centre Hospitalier Lyon-Sud
@fr
Centre hospitalier lyon sud
@fr
prefLabel
centre hospitalier Lyon Sud
@fr
P214
P131
P17
P213
0000 0001 0288 2594
P214
P2427
grid.411430.3
P3500
P4058
P571
1979-01-01T00:00:00Z
P625
Point (4.80514 45.7011)